A Study to See if Tolvaptan Can Delay Dialysis in Infants and Children Who at Enrollment Are 28 Days to Less Than 12 Weeks Old With Autosomal Recessive Polycystic Kidney Disease (ARPKD)
Clinical trial NCT04786574 · WITHDRAWN
Trial details
- NCT number
- NCT04786574
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- WITHDRAWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-01
- Primary completion
- 2025-12-10
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.